(Q40943931)

English

Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell line

scientific article published on 31 May 2015

Statements

Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell line (English)
Stephanie Geuns-Meyer
Victor J Cee
Holly L Deak
Bingfan Du
Brian L Hodous
Hanh Nho Nguyen
Philip R Olivieri
Laurie B Schenkel
Karina R Vaida
Paul Andrews
Annette Bak
Xuhai Be
Pedro J Beltran
Tammy L Bush
Mary K Chaves
Grace Chung
Yang Dai
Patrick Eden
Kelly Hanestad
Liyue Huang
Min-Hwa Jasmine Lin
Jin Tang
Beth Ziegler
Robert Radinsky
Richard Kendall
Vinod F Patel
Marc Payton
31 May 2015
5189-5207

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit